• $2.3M
    Market Cap
  • -94.13%
    1-Year Change
  • Medical Instruments & Supplies
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
393,000
+222.13%
122,000
N/A
N/A
N/A
Research and Development Expense
-9.8M
+3.31%
-9.5M
+101.93%
-4.7M
+139.15%
-2.0M
+8.67%
Depreciation and Amortization Expense
42,000
+16.67%
36,000
+176.92%
13,000
-43.48%
23,000
-45.24%
Total Operating Expenses
16.1M
+10.61%
14.5M
+104.77%
7.1M
+60.29%
4.4M
+9.70%
Operating Profit
-16.1M
+10.61%
-14.5M
+104.77%
-7.1M
+60.29%
-4.4M
+9.70%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
-44,000
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
+100.00%
-44,000
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
-3.3M
-23,657.14%
14,000
N/A
N/A
N/A
-14,000
-73.58%
Income before Taxes
-16.1M
+10.61%
-14.5M
+104.77%
-7.1M
+60.29%
-4.4M
+9.70%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-19.3M
-14.33%
-22.6M
+218.06%
-7.1M
+60.02%
-4.4M
+9.05%
Net Income from Continuing Operations Applicable to Common
N/A
N/A
-22.6M
+218.40%
-7.1M
+60.02%
-4.4M
+9.05%
Basic EPS and Net Income
31.22
-54.38%
68.44
+17,910.53%
0.38
+31.03%
0.29
N/A
Diluted EPS and Net Income
31.22
-54.38%
68.44
+17,910.53%
0.38
+31.03%
0.29
+11.54%
Basic Weighted Average Shares
621,094
N/A
N/A
N/A
20.8M
+34.16%
15.5M
-99.90%
Diluted Weighted Average Shares
621,094
N/A
N/A
N/A
20.8M
+34.16%
15.5M
-99.90%
Balance Sheet
Cash and Cash Equivalents
7.4M
+31.44%
5.6M
+25.04%
4.5M
+94.29%
2.3M
-61.86%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
7.4M
+31.44%
5.6M
+25.04%
4.5M
+94.29%
2.3M
-61.86%
Total Current Assets
7.7M
+32.92%
5.8M
+18.49%
4.9M
+104.62%
2.4M
-61.03%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
254,000
-39.52%
Property and Plant and Equipment and Net
138,000
+45.26%
95,000
+251.85%
27,000
-32.50%
40,000
-42.03%
Total Long-Term Assets
138,000
+45.26%
95,000
+251.85%
27,000
-32.50%
40,000
-42.03%
Total Assets
7.8M
+32.13%
5.9M
+20.94%
4.9M
+101.19%
2.4M
-61.09%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
3.2M
+63,540.00%
5,000
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
4.8M
+274.35%
1.3M
-15.67%
1.5M
+49.26%
1.0M
+14.72%
Total Long-Term Debt
305,000
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
231,000
+13.79%
203,000
+3.57%
196,000
+0.51%
195,000
-14.10%
Total Liabilities
5.0M
-73.54%
18.9M
+1,008.43%
1.7M
+41.39%
1.2M
+8.83%
Retained Earnings
-151.8M
+14.64%
-132.4M
+20.57%
-109.9M
+7.80%
-101.9M
+4.55%
Total Stockholders Equity
2.8M
+121.75%
-13.0M
-506.63%
3.2M
+159.92%
1.2M
-76.14%
Total Shares Outstanding
910,688
+15.04%
791,609
-96.21%
20.9M
+34.78%
15.5M
+0.31%
Cash Flow
Cash from Operating Activities
-15.2M
+22.02%
-12.5M
+90.45%
-6.6M
+75.86%
-3.7M
-1.06%
Capital Expenditures
96,000
-7.69%
104,000
N/A
N/A
N/A
1,000
-80.00%
Cash from Investing Activities
-96,000
-7.69%
-104,000
N/A
N/A
N/A
1,000
+200.00%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
17.0M
+24.01%
13.7M
+57.42%
8.7M
N/A
N/A
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-280.89%
-32.58%
-416.59%
+115.52%
-193.30%
+89.66%
-101.92%
+111.39%
Return on Equity
380.24%
-17.43%
460.53%
+243.64%
-320.62%
+130.80%
-138.92%
+141.44%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
1.61
-64.49%
4.52
+40.51%
3.22
+37.09%
2.35
-66.03%
Cash Ratio
1.55
-64.89%
4.41
+48.29%
2.97
+30.17%
2.28
-66.76%
Debt-to-Equity Ratio
1.23
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
0.44
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow